Advertisement

Radiological imaging software company Optasia Medical of Sudbury has received 510(k) clearance from the U.S. Food and Drug Administration to market its SpineAnalyzer systems in the U.S.

CEO Peter Steiger confirmed the FDA action, saying more details will be released shortly.

SOURCE

Advertisement
Advertisement